Video

Adverse Events Tied to Treatment for Myeloproliferative Neoplasms

Author(s):

Ruben Mesa, M.D.,Rami S. Komrokji, M.D.

Expert perspectives on the possible adverse events patients may encounter while receiving treatment for myeloproliferative neoplasms.

Related Videos
A panel of 3 experts on CML
Related Content
Illustration of blood cells.
November 4th 2024

Jakafi, Pegasys Combination Beneficial in Newly Diagnosed Polycythemia Vera

Alex Biese
Among patients with polycythemia vera, the treatment pairing of Jakafi and Pegasys shows benefits with acceptable toxicity, research showed.
Cancer Horizons podcast logo
January 8th 2024

FDA Stops Lung Cancer Trial, CAR-T Cell Therapy Is Cost Effective, Novel Drug Slows Fibrosis

Alex Biese Brielle Benyon
The year 2024 is now underway. After a busy 2023, we’re now looking back at some of the oncology headlines from the new year.
Image of red blood cells.
October 3rd 2024

Education on MPN Symptoms, Treatments Leads to Greater Involvement in Care

Darlene Dobkowski, MA
An expert explained the importance of education and involvement in care for patients with myeloproliferative neoplasms.
LeVar Burton Helping the MPN Community Through Advocacy and Storytelling
December 16th 2021

LeVar Burton Helping the MPN Community Through Advocacy and Storytelling

Jamie Cesanek Darlene Dobkowski, MA
On this episode of the “Cancer Horizons” podcast, LeVar Burton sits down with CURE® to talk about the importance of MPN awareness and the power of storytelling in advocacy.
Illustration of blood cells.
September 17th 2024

Vonjo Improves Thrombocytopenia, Anemia in Patients With Myelofibrosis

Jax DiEugenio
Vonjo was also shown to improve overall survival in patients with myelofibrosis treated with Vonjo in the real-world setting.
doctor with blood vials
September 1st 2024

A True Partner in Cancer Healing

Wendy Stock, MD
Keri is also a true partner in the management and care of the whole patient.